Viewing Study NCT02997995

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2026-01-24 @ 9:03 PM
Study NCT ID: NCT02997995
Status: COMPLETED
Last Update Posted: 2020-09-30
First Post: 2016-12-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure
Sponsor: UNICANCER
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Estrogen Receptor Positive Tumor View
None Menopause View
None Hormone Antagonist View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T2-T4 Breast cancer View
None Estrogen Receptor Positive Tumor View
None PD-1 View
None Neoadjuvant View
None Immune-attractants View
None lymphocytes activation View